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This study examined the inﬂuence of the N-methyl-D-aspartate receptor (NMDAR) on the modulation of related spinal signaling
after electroacupuncture (EA) treatment in normal rats. Bilateral 2Hz EA stimulations (1-2-3.0mA) were delivered at acupoints
corresponding to Zusanli (ST36) and Sanyinjiao (SP6) in men for 30min. Thermal sensitization was strongly inhibited by EA,
but this analgesia was reduced by preintrathecal injection of the NMDAR antagonist, MK801. Phosphorylation of the NMDAR
NR2B subunit, cAMP response element-binding protein (CREB), and especially phosphatidylinositol 3-kinase (PI3K) were
signiﬁcantly induced by EA. However, these marked phosphorylations were not observed in MK801-pretreated rats. EA analgesia
was reduced by preintrathecal injection with the calcium chelators Quin2 and TMB8, similar to the results evident using MK801.
Phosphorylation of PI3K and CREB induced by EA was also inhibited by TMB8. Calcium inﬂux by NMDAR activation may play
an important role in EA analgesia of normal rats through the modulation of the phosphorylation of spinal PI3K and CREB.
1.Introduction
Electroacupuncture (EA), a new and modern type of tradi-
tional acupuncture, is widely used to treat various types of
diseases in a clinical setting with the alterations of peripheral
electrical stimulation rather than hand manipulation [1]. EA
has an excellent pain relief eﬃcacy proﬁle, and it has been
clinically used as a therapy in Korean medicine. Yet, the basis
of the pain relief remains unclear.
Basic studies concerning the mechanisms of EA-
mediated pain relief have been conducted using an animal
modelofpain[2].TheinductionofEAanalgesiainvolvesthe
N-methyl-D-aspartate receptor (NMDAR), an ionotropic
glutamate receptor [3]. The activation of NMDAR plays an
important role in the induction and maintenance of hyper-
algesia in the spinal dorsal horn [4–6]. Functional NMDAR
are heteromeric complexes including the essential NR1
subunit and one or more of the four NR2 subunits (A–D). In
particular, the NR2B subunit has an important function in
spinal dorsal horn sensory pathways, and phosphorylation
of this subunit plays a role in the induction of long-term
potentiation (LTP), a phenomenon related to central sensiti-
zation[7,8].NMDARcontainingtheNR2Bsubunitlocalizes
in the extrasynaptic membrane [9]. Their activations are
involvedinavarietyofpainstatesincludingthedevelopment
of central sensitization via the induction of LTP in the dorsal
horn of the spinal cord [10, 11].
The induction of LTP requires an increase in the intracel-
lular concentration of calcium in the postsynaptic neuron of
thespinalcord[10,12].NMDAR-mediatedinﬂuxofcalcium
intoneuronsmayinitiatetheintracellularsignalingpathways
such as mitogen-activated protein kinase (MAPK) and other
related proteins. Thus, NMDAR should be important for
signaling cascades in the pain centralization in the spinal
cord [13]. Noxious stimulation releases the neurotransmitter
glutamate,andtheactivationofthecorrespondingglutamate
receptors in postsynaptic dorsal horn neurons induces
central sensitization [14, 15].
Activation of NMDAR has been implicated in noxious
and inﬂammatory stimulation-evoked extracellular signal-
regulatedkinase(ERK)andcAMPresponseelement-binding2 Evidence-Based Complementary and Alternative Medicine
protein (CREB) activation in dorsal horn neurons [15].
The ERK cascades are suggested to contribute to excitatory
plasticity in the spinal cord [16]. Activation of intracellu-
lar signaling pathways involving p38 and ERK contribute
importantly to synaptic plasticity underlying spinal neuronal
sensitization.Theseactivationsinthespinalcordarereduced
by antagonists of NMDAR [17]. The phosphatidylinositol
3-kinase (PI3K) inhibitor inhibits pain-related behavior in
a dose-dependent manner and is a major factor in the
expression of central sensitization after noxious stimuli [18].
Following concomitant use of EA with NMDAR antag-
onist, there was a diﬀerence in the experimental results
between normal and pain animal models. The concomitant
use of EA with NMDAR antagonist can synergistically
alleviate pain in carrageenan-treated rats [19]. However,
following the treatment with NMDAR antagonist, EA anal-
gesia is impaired in normal rats [3]. The present study was
performed under the hypothesis that EA analgesia has a
diﬀerent action between normal and pain animal models
and produces a basic analgesic eﬀect as a mild nociceptive
stimulation.
The aim of the present study was to investigate the role
of EA on the NR2B subunit of NMDAR and pain-related
signaling proteins in a normal animal model. The link of
phosphorylation between the NMDAR NR2B subunit and
ERK, p38, PI3K, and CREB was assessed in the spinal cord
of normal animal presenting EA analgesia.
2. Methods
2.1. Animals. Male Sprague-Dawley rats averaging 180g in
weight were obtained from Dooyeol Biotech (Seoul, Korea).
T h er a t sw e r eh o u s e da t2 2 ◦C under alternating 12 hour
cycles of dark and light and were fed a commercial diet
and allowed tap water ad libitum starting 1 week before the
study and continuing throughout the study. All experiments
wereapprovedbythePusanNationalUniversityAnimalCare
and Use Committee in accordance with the Council of the
International Association for the Study of Pain of December
1982. Each group consisted of six rats for the behavioral
test and tree rats for Western and immunohistochemical
analysis. All treatments were administered under isoﬂurane
(Choongwae, Seoul, Korea) anesthesia, which was provided
using a model VIP 3000 calibrated vaporizer (Midmark,
Orchard Park, OH, USA).
2.2. EA Stimulation. Under light gaseous anesthesia (1.0%
isoﬂurane in air), two stainless-steel 0.2mm-diameter nee-
dles were inserted to a depth of approximately 3mm into
each hind leg at the acupoints corresponding to Zusanli
(ST36) and Sanyinjiao (SP6) in men and were connected to
a Pulsemaster Multichannel Stimulator SYS-A300 electrical
stimulator (Word Precision Instruments, Berlin, Germany).
EA was accomplished with 2Hz stimulation for 30min and
an intensity set at 1mA and increasing stepwise to 2mA
and 3mA, with each step lasting 10min. For sham-EA
control, acupuncture needles were inserted bilaterally at a
point lateral to the aforementioned acupoints without any
electrical stimulation.
2.3. Intrathecal Injection. Intrathecal catheterization was
performed as previously described under 1% isoﬂurane
anesthesia [20]. Brieﬂy, a PE-10 intrathecal catheter was
inserted through the slit in the L4-5 level of the vertebrate to
reach the lumbar enlargement of the spinal cord. Two days
after surgery, only those rats without overt signs of spinal
cordorrootdamage,suchasparalysisorlameness,wereused
for experimentation. The NMDAR antagonist MK801 and
calcium chelator Quin2 or TMB8 were dissolved in sterile
saline and injected intrathecally at a volume of 10μLv i aa
catheter within 1min. The catheter was then ﬁlled with 8μL
of saline for ﬂushing. Drugs were administered once into
the subarachnoid space of the spinal cord 30min prior to
EA stimulation. The vehicle control group for drugs received
injections of identical amounts of phosphate-buﬀered saline
(PBS) via an identical method.
2.4. Measurements of Thermal Hyperalgesia. The heat paw
withdrawal latency (PWL) of six rats each group was
measured by the plantar test using a model 37370 apparatus
(Ugo-Basile, Comerio, Italy). The rats were placed in six
separate cages (17 × 11.5 × 14cm) for 30min after EA
treatment, and thermal thresholds of the left hind paw were
assessed three times with a 5min interval between trials.
The mean values were taken as the PWL. The intensity of
the infrared generator was adjusted to produce withdrawal
latencies of approximately 8–10s (80 infrared intensity). A
cut-oﬀ period of 15s was used. The latency responses were
monitored from 30min after EA stimulation with or without
injection of MK801 and the calcium chelators. Rats not
treated with EA were also placed under gaseous anesthesia,
and the PWL was then measured.
2.5. Western Blot. To examine changes in the NMDAR NR2B
subunit, ERK, p38, PI3K, and CREB, the L4-5 segments
of the spinal cords were removed 0, 10, 30, 60, 90 and
120min after the beginning of EA stimulation. L4-5 segment
of the spinal cord, 5mm in length, involved partially lumbar
enlargement of the spinal cord, in three rats of each group
by laminectomy under anesthesia induced by intraperitoneal
injectionof4%chloralhydrate(300mg/kg).Thespinalcords
w e r ew a s h e di nc o l dH E P E Sb u ﬀer and homogenized in nine
volumes of lysis buﬀer. Equal amounts of proteins were then
separated by 8–12% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE), after which the resolved
proteins were transferred to a nitrocellulose membrane
(Whatman, Dassel, Germany) that was subsequently blocked
with 5% nonfat milk in Tris-buﬀered saline containing 0.4%
Tween 20.
The membranes were incubated with anti-NR2B (Mil-
lipore, Billerica, MA, USA), anti-phospho-NR2B (pNR2B,
ser1303;UpstateBiotechnology,LakePlacid,NY,USA),anti-
ERK (Santa Cruz Biotechnology, Santa Cruz, CA, USA),
anti-phospho-ERK (pERK, thr202/tyr 204; Cell Signaling
Technology, Danvers, MA, USA), anti-p38 (Santa Cruz
Biotechnology), anti-phospho-p38 (pp38, thr180/tyr182;
Cell Signaling Technology), anti-PI3K (Cell Signaling Tech-
nology), anti-phospho-PI3K(pPI3K, Tyr458; Cell Signaling
Technology), anti-CREB (Cell Signaling Technology) orEvidence-Based Complementary and Alternative Medicine 3
antiphospho-CREB (pCREB, ser133; Cell Signaling Technol-
ogy) for 1-2h at room temperature, after which the blots
were incubated with horseradish peroxidase-conjugated sec-
ondary antibody, and the antibody-speciﬁc proteins were
visualized using an enhanced chemiluminescence detection
system according to the recommended procedure (Pierce,
Rockford, IL, USA). β-actin was used as a loading control
for all experiments. Quantiﬁcation of immunoreactivity
corresponding to the total and phosphorylated bands was
performed by densitometric analysis using a MultiGauge
Version 3.0 (Fujiﬁlm, Tokyo, Japan).
2.6. Immunohistochemistry. The L4-5 segments of the spinal
cords were removed as described above for Western blot in
three diﬀerent rats in each group. Tissues were ﬁxed in 4%
paraformaldehyde and immersed in 30% sucrose for 48h
at 4◦C for cryoprotection. Frozen 14μm-thick sections were
thenpreparedandpreincubatedinablockingsolution(CAS-
block, Invitrogen-Molecular Probes, Camorillo, CA, USA)
for 9min at room temperature. The sections were incubated
with the following primary antibodies overnight in PBS at
4◦C: pPI3K (Tyr607, ABcam, Cambridge, UK), pCREB (Ser
133, Santa Cruz Biotechnology) and antineuronal nuclei
(NeuN, Millipore-Chemicon, Billerica, MA, USA). After
being washed with PBS-containing Tween-20 (PBST), the
sections were incubated with the secondary antibody, goat
anti-rabbit IgG-TR (Santa Cruz Biotechnology), and anti-
mouse IgG-FITC (Vector Laboratories, Burlingame, CA) for
2h at room temperature and then washed with PBST. Slides
were mounted in the mounting medium for ﬂuorescence
(Vector Laboratories, Inc. Burlingame, CA), and images
were captured using a LSM 510 laser scanning confocal
microscope (Zeiss, Oberkohen, Germany).
2.7. Data Analyses. Data are expressed as the mean ± SEM.
Data were analyzed by multifactorial analysis of variance
(ANOVA) using the Sigmastat statistical program Version
11.0 (Systat Software, San Jose, CA, USA). Behavioral
analysis was performed by a two-way ANOVA post hoc test
via Tukey’s test. Western blot analysis was performed using a
one-way ANOVA post hoc test via Tukey’s test. A P<0.05
was considered to be statistically signiﬁcant.
3. Results
3.1. Behavioral Analysis on EA with or without MK801
Pretreatment. Rats usually resumed full activity within 2–
5min of the cessation of isoﬂurane anesthesia, regardless
of whether they received EA stimulation. Behavioral test
measured the basal threshold of heat PWL for the left
hindpaw 1h before EA stimulations, and it was measured
at 30min intervals at 30, 60, and 90min following EA
stimulation. EA produced an analgesia characterized by a
markedly higher PWL proﬁle as compared with the normal
control rat within 30min after stimulation. But, ﬁndings
were similar to control rats 60min following EA. With EA
stimulations following pretreatment with MK801, there was
a lower degree of PWL as compared with EA-treated rats;
theMK801 eﬀectwas dose dependent. Signiﬁcant diﬀerences
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Figure 1:EﬀectofEAstimulationwithorwithoutMK801pretreat-
ment on the PWL to thermal stimuli. Each point indicates the mean
± SEM (n = 6). EA-stimulated rats showed a signiﬁcant analgesic
eﬀect compared with normal control rats, and pretreatment with
MK801 inhibited EA-induced analgesia.
∗∗P < 0.01 and
∗∗∗P <
0.001 compared with control rats; #P < 0.05, ##P < 0.01, and
###P < 0.001 compared with EA-treated rats.
in PWL were observed in the MK801-treated rats within 30
and 60min after EA stimulation. These results suggested that
the pretreatment with MK801 impaired EA analgesia, which
implicated NMDAR in EA analgesia (Figure 1).
3.2. NMDAR NR2B Subunit and Related Proteins Analyses on
EA with or without MK801 Pretreatment. The ﬁrst experi-
ment examined the induction of the total and phosphory-
lated NMDAR NR2B subunit, ERK, p38, PI3K, and CREB
in normal rats. Next, the NMDAR antagonist MK801 was
intrathecally preinjected to identify the proteins associated
with NMDAR in the spinal cord and checked for time-
dependentalterations.FollowingEAstimulations,therewere
no time-dependent alterations in the total protein, but there
was a marked degree of changes in the phosphorylated
form of NR2B, PI3K, and CREB. The phosphorylation of
NMDAR NR2B was signiﬁcantly increased at 30min after
the beginning of EA stimulation. Phosphorylation of PI3K
was signiﬁcantly increased at 30min after the beginning of
EA stimulation and between 30 and 90min after EA. Phos-
phorylation of CREB was signiﬁcantly increased 30min after
the beginning of EA stimulation. However, phosphorylation
of ERK and p38 showed no signiﬁcant changes (Figure 2).
Following treatment with the NMDAR antagonist
MK801, the induction of the total and phosphorylated
proteinswasevaluated.Similartotheaboveresults,therewas
no marked degree of change in the total protein. The signiﬁ-
cant alteration of NR2B phosphorylation was not observed
at 30min after the beginning of EA, and this expression4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Western blot (a) and densitometric analysis for NMDAR NR2B subunit (b), PI3K (c), and CREB (d) in the L4-5 segment of the
spinal cord in EA-treated rats. The level of each protein is expressed as a percentage of the control. Each single experiment was conducted
on three pooled animals. The panel represents a typical result from three independent experiments. The phosphorylation of NR2B subunit
increased signiﬁcantly at 30min from the beginning of EA stimulation. The phosphorylation of PI3K was signiﬁcantly increased at 30min
from the beginning of EA stimulation and between 30 and 90min after EA. The phosphorylation of CREB was signiﬁcantly increased at
30min from the beginning of EA stimulation.
∗∗P < 0.01,
∗∗∗P < 0.001.
was somewhat decreased after EA stimulation. Although
there were no signiﬁcant changes, ERK phosphorylation was
increased at 10min from the beginning of EA. Additionally,
the marked increases of PI3K and CREB phosphorylation,
which were formed following EA stimulation, were not
observed following MK801 pretreatment. Especially, CREB
showed a signiﬁcantly lower phosphorylation from 60min
on following EA stimulations with MK801 pretreatment
(Figure 3).
3.3. Eﬀects of Calcium Chelator on EA with or without MK801
Pretreatment. NMDAR is a receptor involved in calcium
inﬂux into neurons. Accordingly, with the assumption that
the above results originated from the intracellular calcium
inﬂux via NMDAR, pretreatment with the calcium chelators
Quin2 and TMB8 was carried out. Both calcium chelators
impaired EA analgesia in a similar manner to the pretreat-
ment with NMDAR antagonist MK801 in the behavioral test
(Figure 4). Following the pretreatment with TMB8, changes
in the phosphorylation of CREB and PI3K were evaluated
at 30min from the beginning of EA stimulation. Following
the pretreatment with calcium chelator, the phosphorylation
of CREB and PI3K due to EA stimulations was signiﬁ-
cantly decreased (Figure 5). To localize pPI3K and pCREB
expression and distribution in the spinal cord, we employed
immunoﬂuorescence staining with neuron markers NeuN
in normal and EA-treated rats. Double-labeling staining
showed a large proportion of pPI3K or pCREB and NeuN
colocalization in the laminae IV-VI of the dorsal horn
(Figure 6). While a similar distribution of pPI3K and pCREB
wasobservedinneuronalcells,strongexpressionofPI3Kwas
evident in EA-treated rats compared with normal rats.
4. Discussion
EA stimulation markedly reduces inﬂammatory hyperalgesia
by inhibiting the release of glutamate in the spinal dorsal
horn, and NMDAR antagonists display an antinociceptive
action in an inﬂammatory pain model [19]. Induction
of EA analgesia involves NMDAR and is inhibited by a
NMDAR antagonist in a normal rat [3]. However, NMDAR-
mediated EA-induced analgesic eﬀects, especially the under-
lying mechanism(s) of EA in normal rats, have received
relatively little attention.
To clarify the mechanisms by which EA alleviates pain,
studies conducted on normal rats as well as investigations on
painalleviationinapainmodelwouldalsobeofsigniﬁcance.
We performed 2Hz EA stimulation at ST36 and SP6 acu-
points, which previously showed signiﬁcant analgesic eﬀects
and phosphorylation of the NMDAR subunit [21]. The goal
of the present study was to observe the time-dependent
alteration in the spinal NMDA NR2B subunit, ERK, p38,Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Western blot (a) and densitometric analysis for NMDAR NR2B subunit (b), PI3K (c), and CREB (d) in the L4-5 segment of the
spinal cord in MK801- and EA-treated rats. The level of each protein is expressed as a percentage of the control. Each single experiment was
conducted on three pooled animals. The panel represents a typical result from three independent experiments. EA-induced phosphorylation
of NR2B subunit and PI3K was not observed by MK801 pretreatment, and a signiﬁcant lower phosphorylation of CREB was detected from
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PI3K and CREB phosphorylation in EA-stimulated rats that
had or had not been pretreated with the NMDAR antagonist
MK801.
Analgesia induced by EA was observed, and the eﬀects
of MK801 pretreatment on heat PWL were assessed. EA
stimulation resulted in persistent analgesia within 60min
after EA treatment. However, EA-induced analgesia was sig-
niﬁcantly abolished by pretreatment with MK801 (Figure 1).
Behavioral studies demonstrated that MK801 profoundly
inhibited the PWL of EA-induced analgesia, similar to pre-
vious observations [3]. Our behavioral results may indicate
the involvement of NMDAR in induction or maintenance of
EA analgesia.
NMDARs are important in the plasticity of the synaptic
processes of the nervous system, such as sensitization of
the nociceptive pathways [22]. The inhibition of NMDAR
containing the NR2B subunit in the superﬁcial dorsal horn
of the spinal cord suppresses nociceptive transmission, and
thesereceptorsseemtohaveahigherconductancethanother
NMDARs [10, 23]. The NR2B subunit may be important in
pain states where a possible build-up of glutamate activates
extrasynaptic NMDAR in the spinal cord [9, 10].
NMDAR containing the NR2B subunit plays a role in
the development of central sensitization via the induction of
LTP in dorsal horn nociceptive synaptic transmission [11].
LTP requires an increase in the intracellular concentration of6 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Immunohistochemical localization of pPI3K in the dorsal horn L4-5 segment in normal and EA-treated rats. The expression of
pPI3K (red) was usually detected in the laminae IV-VI regions of dorsal horn of the spinal cord. NeuN (green) was also detected in the
similar region, and merged image showed that pPI3K and NeuN were colocalized. Scale bar = 200μm.
calcium in the postsynaptic neurons of the spinal cord [12].
NMDARs function as a calcium channel. LTP in dorsal horn
neurons are dependent on NMDAR containing the NR2B
subunit, and this receptor is involved in use-dependent
sensitization at the spinal level [10].
The elevation of intracellular calcium activates a cascade
of biochemical events and ultimately leads to altered gene
expression [24,25].CalciumentryintoneuronsviaNMDAR
may initiate MAPKs and the PI3K signaling cascade. Thus,
it was appropriate to examine the induction of total and
phosphorylated ERK, p38, PI3K, and CREB, as well as the
NMDA NR2B subunit during and following EA stimulation.
Phosphorylation of the NMDAR NR2B subunit was
signiﬁcantlyinducedbyEAtreatment.Inaddition,phospho-
rylation of PI3K, CREB, and especially PI3K was strongly
induced by EA stimulation, but that of ERK and p38
was not induced (Figure 2). To demonstrate the possible
involvement of NMDAR, the NMDAR antagonist MK-801
was administrated intrathecally before the EA stimulation.
EA-induced phosphorylation of the NMDAR NR2B subunit,Evidence-Based Complementary and Alternative Medicine 7
PI3K, and CREB was strongly inhibited by MK801 pretreat-
ment (Figure 3). These results indicate that EA analgesia
may be produced by phosphorylation of PI3K and CREB via
NMDAR NR2B subunit activation in the spinal dorsal horn.
CREB and PI3K may be important intracellular controllers
of EA analgesia in the spinal cord with the NMDAR NR2B
subunit.
PI3K is a lipid kinase that generates membrane-asso-
ciated second messengers, which are able to activate several
signaling cascades and cellular processes [18, 26]. PI3K
is involved in a transcription-independent and short-term
form of spinal plasticity, termed wind-up, which may
underlie central sensitization in C-ﬁber-mediated evoked
responses, and PI3K inhibition reduces the phosphorylation
of the NR2B subunit of NMDAR [18].
CREB signaling plays a role in the long-term facili-
tation after noxious stimuli in the spinal cord neurons.
CREB phosphorylation represents a better marker than c-
fos expression for neuronal activity after noxious stimulation
because its induction is more rapid and more sensitive
[27]. The NMDAR antagonist MK801 markedly suppressed
EA-induced CREB phosphorylation in the present study,
corroborating the previous demonstrating that MK801-
mediated suppression of spinal cord associated pain in a
formalin-induced pain model [27].
Inﬂux of calcium via NMDARs leads to the phosphoryla-
tion and activation of CaMKII, and CAMKII activation may
also aﬀect phosphorylation of the NMDAR NR2B subunit
[18]. Therefore, we hypothesized that calcium might be
involved in EA analgesia in the spinal cord. To assess this
hypothesis, we investigated the eﬀect of calcium chelators
on EA analgesia, animal behavior (PWL) and subsequently
examined the phosphorylation of PI3K and CREB by
Western blotting. A diminished PWL was apparent in rats
pretreated with calcium chelator as compared with EA-
treated rats; similar results were obtained upon pretreatment
with NMDAR antagonist (Figure 4). The phosphorylation of
PI3K and CREB due to EA stimulation was decreased by
pretreatment with calcium chelator (Figure 5). These results
implicate PI3K and CREB as key players in EA analgesia, as
in the central sensitization of noxious stimulation. Phospho-
rylation of the NMDAR NR2B subunit provokes increased
calciuminﬂuxuponEAstimulation,whichmayinducePI3K
andCREBphosphorylationassensitization-likemechanisms
in the dorsal horn of the spinal cord.
Low-frequency EA activates betaendorphin and enkep-
halin systems through their receptors, which are expressed in
the spinal cord and which contribute to the modulation of
nociceptive transmission [1]. The relationship between PI3K
activation and EA analgesia in normal rats remains unclear
in the nervous system. But PI3K activation contributes to
calcium-regulated opioid release from polymorphonuclear
cells, the major source of opioids, and thereby inhibits
inﬂammatory pain [28]. Further studies are need concerning
the interaction between opioid system and PI3K signaling in
spinal nociception during EA stimulation.
Concerning the localization of pPI3K and pCREB
induced by EA stimulation, these reactions were colocalized
with neuronal marker and were found mainly in laminae
Peripheral stimulation by EA
Mild noxious stimulation of EA
EA analgesia 
in normal rats
PI3K
CREB
Glutamate
NMDAR
Ca+
Figure 7: Proposed schematic diagram for of EA-induced analgesia
in normal rats. Peripheral stimulation by EA induces glutamate
releaseinthespinalcorddorsalhornthisneurotransmitteractivates
NMDAR.AppropriateinﬂuxofcalciumviaactivatedNMDARleads
to the phosphorylation of the PI3K and CREB cascade, especially
PI3K, manifesting as analgesia. The dotted line denotes where
further study is needed to clarify an interaction between PI3K and
EA analgesia in normal rats.
IV-VI in the dorsal horn (Figure 6). Primary aﬀerents of
low-threshold Aα/Aβ mechanoreceptors terminate mainly in
laminae III–V [29]. TheseresultssuggestthatEA stimulation
induces expression of PI3K and CREB in neuronal cells
distributed in laminae IV-VI.
In a pain animal model, calcium inﬂux via NMDAR is
involved in the spinal centralization and induces persistent
pain. However, depending on the intracellular concentration
of calcium, the results might vary. An appropriate level of
calcium produces analgesia with the activation of signaling
protein. But, an excessively higher level of intracellular
calcium contradictorily induces and maintains pain.
In normal rats, the intracellular calcium inﬂux was
inducedthroughtheactivationofNMDAR.Thus,therelated
proteins were activated, and this led to the EA analgesia. Put
another way, as an appropriate mild noxious stimulation, EA
stimulation may induce an appropriate degree of intracellu-
lar calcium inﬂux by NMDAR and phosphorylate PI3K and
CREB, producing EA analgesia.
I nt h ep r e s e n ts t u d y ,n o r m a lr a t sw e r es e q u e n t i a l l y
administered EA stimulations at magnitudes of 1, 2, and
3mA in 10min intervals and induced EA analgesia over a
total period of 30min. The degree of pain control reached
a maximum level when the stimulations were given for
approximately 20min with lower 1mA in an inﬂammatory
pain model in our lab. In a prior study, only a high frequency
of electrical stimulation for C-ﬁbers (3mA) was capable
of activating NMDAR and inducing the intracellular signal8 Evidence-Based Complementary and Alternative Medicine
pathway in the spinal cord [13]. The frequency and intensity
of electrical stimulation may be an important factor to
activate the intracellular signal pathway.
Accordingly, if EA stimulations evoke EA analgesia as a
mild noxious stimulation, this would produce an analgesic
eﬀect with the application of EA whose magnitude was
of an appropriate degree in a dependent manner to the
severity of pain. Based on cases not appropriate for a pain
model, following the treatment with extremely high degree
ofstimulationsoralong-termtreatmentwithEA,painmight
be aggravated.
Consequently, we suppose that EA analgesia in a normal
rat has a diﬀerent eﬀect on modulating spinal NMDAR-
related signaling in rats with inﬂammatory or neuropathic
painandproposepossibleschematicdiagram(Figure 7).The
present results suggest that appropriate inﬂux of calcium via
NMDAR in normal rats induces related PI3K and CREB
phosphorylation, especially PI3K, manifesting as analgesia.
EA analgesia in normal rats may depend on the intensity
of the applied EA stimulation. In the application of EA to
a pain model, basic studies should also be conducted to
examine such parameters as the frequency and intensity of
EA depending on the diseases.
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